Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis
Crossref DOI link: https://doi.org/10.1038/s41598-019-45785-w
Published Online: 2019-06-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Yunlei
Liu, Xishi
Guo, Sun-Wei http://orcid.org/0000-0002-8511-7624
Text and Data Mining valid from 2019-06-25
Version of Record valid from 2019-06-25
Article History
Received: 14 January 2019
Accepted: 14 June 2019
First Online: 25 June 2019
Competing Interests
: The authors declare no competing interests.